Abstract
Two ruthenium(II) porphyrin complexes [Ru(L)2Cl(PTP)]+ (L = bpy, 1, phen; 2; PTP = 5-(3′-pyridyl)-10,15,20-trimethylphenylporphyrin) have been synthesized and their antitumor activities have been evaluated by MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) methods. Both complexes exhibit high inhibitory activity against the growth of human cervical carcinoma cell line HeLa, both with and without light treatment. However, when treated with light, the inhibitory activity for both complexes increases at low drug concentration. Spectroscopic studies show that both complexes can bind to HeLa DNA tightly with apparent binding constants of 1.54(±0.07) × 105 and 1.01(±0.02) × 105 M−1 for 1 and 2, respectively.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
